توضیحاتی در مورد کتاب MAO — The Mother of all Amine Oxidases
نام کتاب : MAO — The Mother of all Amine Oxidases
ویرایش : 1
عنوان ترجمه شده به فارسی : MAO - مادر تمام آمین اکسیدازها
سری : Journal of Neural Transmission. Supplement 52
نویسندگان : J. C. Shih Ph.D., K. Chen, R. M. Geha (auth.), Prof. Dr. J. P. M. Finberg, Prof. Dr. M. B. H. Youdim, Prof. Dr. P. Riederer, Prof. Dr. K. F. Tipton (eds.)
ناشر : Springer-Verlag Wien
سال نشر : 1998
تعداد صفحات : 359
ISBN (شابک) : 9783211830376 , 9783709164990
زبان کتاب : English
فرمت کتاب : pdf
حجم کتاب : 21 مگابایت
بعد از تکمیل فرایند پرداخت لینک دانلود کتاب ارائه خواهد شد. درصورت ثبت نام و ورود به حساب کاربری خود قادر خواهید بود لیست کتاب های خریداری شده را مشاهده فرمایید.
توضیحاتی در مورد کتاب :
مونوآمین اکسیداز (MAO) با اختلالات روانپزشکی و عصبی مرتبط است، زیرا مهارکنندههای آنزیم از نظر بالینی برای درمان اختلالات عاطفی و بیماری پارکینسون استفاده میشوند. یکی از جنبههای جدید جالب MAO، وقوع حذف ژنهای کدکننده یک یا زیرگروه آنزیم (A یا B) در جمعیت انسانی است. این منجر به احتمال وجود یک مبنای ژنتیکی برای اختلالات روانپزشکی بر اساس MAO می شود. موضوعاتی با حذف های نوع A یا B و حذف های ترکیبی شرح داده شده اند. در گروه اول 6 مقاله ای این کتاب، وقوع و خصوصیات این فنوتیپ ها و همچنین ساختار ژن های MAO مورد بررسی قرار گرفته است. پیشرفتها در بیوشیمی زیرگروههای MAO و عملکرد فیزیولوژیکی و محلیسازی آنها در مغز و محیط را شامل میشود. بخشهای دیگر کتاب به عملکرد محافظتی عصبی مهارکنندههای MAO و فارماکولوژی آنها، بهویژه فارماکولوژی مهارکنندههای جدید MAO-B میپردازد.
فهرست مطالب :
Front Matter....Pages I-XIX
Determination of regions important for Monoamine Oxidase (MAO) A and B substrate and inhibitor selectivities....Pages 1-8
Monoamine oxidase A deficiency: Biogenic amine metabolites in random urine samples....Pages 9-15
Relationship between monoamine oxidase (MAO) A specific activity and proportion of human skin fibroblasts which express the enzyme in culture....Pages 17-27
Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?....Pages 29-38
Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline)....Pages 39-48
Experience with tranylcypromine in early Parkinson’s disease....Pages 49-61
Deprenyl monotherapy improves visuo-motor control in early parkinsonism....Pages 63-69
Endogenous monoamine oxidase A inhibitory activity (tribulin), measured in saliva, is related to cardiovascular reactivity in normal individuals....Pages 71-77
MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients....Pages 79-85
Modulation of glutamate neurotoxicity in the transformed cell culture by monoamine oxidase inhibitors, clorgyline and deprenyl....Pages 87-91
A cell culture model of cerebral ischemia as a convenient system to screen for neuroprotective drugs....Pages 93-98
Neuroprotection by selegiline and other MAO inhibitors....Pages 99-107
The neuroprotective and neuronal rescue effects of (—)-deprenyl....Pages 109-123
Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines....Pages 125-138
Substrate regulation of monoamine oxidases....Pages 139-147
Monoamine oxidases and related amine oxidases as phase I enzymes in the metabolism of xenobiotics....Pages 149-171
Monoamine oxidases: from brain maps to physiology and transgenics to pathophysiology....Pages 173-187
Structure-function relationships of mitochondrial monoamine oxidase A and B: chimaeric enzymes and site-directed mutagenesis studies....Pages 189-200
Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes....Pages 201-216
Monoamine oxidase activities in human cystic and colonic arteries — influence of age....Pages 217-223
Influence of maturation and ageing on the biotransformation of noradrenaline in the rat....Pages 225-232
The oxidation of dopamine and epinine by the two forms of monoamine oxidase from rat liver....Pages 233-238
Properties and functions of tissue-bound semicarbazide-sensitive amine oxidases in isolated cell preparations and cell cultures....Pages 239-250
Studies on the time-dependent activation of microsomal semicarbazide-sensitive amine oxidase....Pages 251-257
Studies on the behaviour of semicarbazide-sensitive amine oxidase in Sprague-Dawley rats treated with the monoamine oxidase inhibitor tranylcypromine....Pages 259-264
Semicarbazide-sensitive amine oxidase in pig heart....Pages 265-270
Chronic TVP-1012 (rasagiline) dose — activity response of monoamine oxidases A and B in the brain of the common marmoset....Pages 271-278
Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey....Pages 279-285
Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders....Pages 287-300
(R)(+)-N-Propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B....Pages 301-305
Function of endogenous monoamine oxidase inhibitors (tribulin)....Pages 307-313
Long term administration of (—)-deprenyl increases mortality in male Wistar rats....Pages 315-320
Selegiline as immunostimulant — a novel mechanism of action?....Pages 321-328
Clorgyline effect on pineal melatonin biosynthesis in rats with lesioned suprachiasmatic nuclei....Pages 329-332
The effect of MAO-A inhibition and cold-immobilization stress on N-acetylserotonin and melatonin in SHR and WKY rats....Pages 333-336
The influence of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase A and GABA A receptor binding....Pages 337-342
“In vitro” effect of some 5-hydroxy-indolalkylamine derivatives on monoamine uptake system....Pages 343-349
N-Alkyloxycarbonyl derivatives of ethylene diamine as monoamine oxidase inhibitors....Pages 351-355
Back Matter....Pages 357-363
توضیحاتی در مورد کتاب به زبان اصلی :
Monoamine oxidase (MAO) is linked to psychiatric and neurological disorders, because inhibitors of the enzyme are used clinically for treatment of affective disorders and Parkinson’s disease. One of the interesting new aspects of MAO is the occurrence in the human population of deletions of genes coding for one or the other enzyme subtype (A or B). This leads to the possibility of a genetic basis for psychiatric disorders based on MAO. Subjects with deletions of type A or B, and combined deletions, have been described. In the first group of 6 papers in this book, the occurrence and characterization of these phenotypes, as well as the structure of MAO genes, is explored. Advances in the biochemistry of MAO subtypes and their physiological function and localization in brain and periphery is included. Other sections of the book deal with the neuroprotective action of MAO inhibitors and their pharmacology, especially the pharmacology of new MAO-B inhibitors.